Curaleaf Holdings

Company Description

Curaleaf Holdings, Inc. is an international provider of consumer products in cannabis. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof, provide service, product selection and accessibility across the medical and adult use markets. It has operations in about 17 states and operates 151 dispensaries, 19 cultivation sites and 20 manufacturing facilities, through which it sells cannabis through wholesale channels. The Company places a premium on populated, limited license states, including Arizona, Connecticut, Florida, Illinois, Maryland, Massachusetts, Nevada, New York, New Jersey, North Dakota, Ohio and Pennsylvania. It cultivates, processes, markets and/or dispenses a wide range of permitted cannabis products across its operating markets, including flowers, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, mints and lozenges, topical balms and lotions, tinctures, and others.

Analysis

ANALYSIS: With an Obermatt 360° View of 14 (better than 14% compared with alternatives), overall professional sentiment and financial characteristics for the stock Curaleaf Holdings are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Curaleaf Holdings. The consolidated Growth Rank has a good rank of 51, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 51% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 42 means that the share price of Curaleaf Holdings is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 58% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 22, which means that the company has a riskier financing structure than 78% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 39, indicating professional investors are more pessimistic about the stock than for 61% of alternative investment opportunities. ...read more

Country

USA

Industry Pharmaceuticals

Size Small

Website ir.curaleaf.com

Index

Add to Watchlist

See Similar Stocks

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.